Evidence map›Paper›PMID 24503582›Full record

ArticlePloS one2014

Delineating the role of histamine-1- and -4-receptors in a mouse model of Th2-dependent antigen-specific skin inflammation.

Subhashree Mahapatra, Melanie Albrecht, Barbara Behrens, Adan Jirmo, Georg Behrens, Christina Hartwig, Detlef Neumann, Ulrike Raap, Heike Bähre, Christina Herrick and 1 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 25 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Enigmatic Histamine Receptor HLife (Basel, Switzerland) · 2020
    Review
  5. The role of the histamine HBritish journal of pharmacology · 2020
    Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 2 countries.

Subhashree MahapatraDepartment for Pediatric Pneumology, Allergology and Neonatology, Medical School Hannover, Hannover, Germany.
Melanie AlbrechtDepartment for Pediatric Pneumology, Allergology and Neonatology, Medical School Hannover, Hannover, Germany.
Barbara BehrensDepartment for Pediatric Pneumology, Allergology and Neonatology, Medical School Hannover, Hannover, Germany.
Adan JirmoDepartment of Clinical Immunology and Rheumatology, Medical School Hannover, Hannover, Germany.
Georg BehrensDepartment of Clinical Immunology and Rheumatology, Medical School Hannover, Hannover, Germany.
Christina HartwigInstitute of Pharmacology, Medical School Hannover, Hannover, Germany.
Detlef NeumannInstitute of Pharmacology, Medical School Hannover, Hannover, Germany.
Ulrike RaapDepartment of Dermatology and Allergy, Medical School Hannover, Hannover, Germany.
Heike BähreInstitute of Pharmacology, Medical School Hannover, Hannover, Germany.
Christina HerrickDepartment of Dermatology, Yale School of Medicine, New Haven, Connecticut, United States of America.
Anna-Maria DittrichDepartment for Pediatric Pneumology, Allergology and Neonatology, Medical School Hannover, Hannover, Germany.
Medizinische Hochschule Hannover · DEYale University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHistamine drives pruritus in allergic skin diseases which clinically constitutes a most disruptive symptom. Skin pathology in allergic skin diseases is crucially influenced by different T-helper subsets. However, the contribution of different histamine-receptors to T-helper cell dependent skin pathology has not been definitively answered. Models which can specifically address the functional role of T-helper subsets and the mediators involved are therefore valuable to gain further insights into molecular pathways which contribute to allergic skin disease. They might also be helpful to probe amendable therapeutic interventions such as histamine-receptor antagonism.

objectiveEstablishing an adoptive transfer model for antigen-specific Th cells, we aimed to delineate the role of histamine H1- and H4-receptors in Th2-dependent skin inflammation.

methodsIn-vitro differentiated and OVA primed Th2 cells were adoptively transferred into congenic recipient mice. In vivo treatment with specific histamine H1- and H4-receptor antagonists was performed to analyze the contribution of these histamine-receptors to Th2-dependent skin pathology in our model. Analysis four days after epicutaneous challenge comprised skin histology, flow cytometric detection of transferred T-helper cells and analysis of antigen-cytokine profiles in skin-draining lymph nodes.

resultsUse of specific H1- and H4-receptor antagonists revealed a crucial role for H1- and H4-receptors for Th2 migration and cytokine secretion in a Th2-driven model of skin inflammation. While H1- and H4-receptor antagonists both reduced Th2 recruitment to the site of challenge, local cytokine responses in skin-draining lymph nodes were only reduced by the combined application of H1- and H4-receptor antagonists and mast cell counts remained altogether unchanged by either H1R-, H4R- or combined antagonism.

conclusionOur model demonstrates a role for H1- and H4-receptors in Th2 cell infiltration and cytokine secretion in allergic skin diseases and suggests further studies to evaluate these findings for therapeutic approaches.

Indexed as

Adoptive TransferAnimalsCell CountCell MovementCell PolarityCytokinesDisease Models, AnimalDose-Response Relationship, ImmunologicEpitopesFemaleHistamine AntagonistsInflammationMast CellsMice, Inbred BALB CReceptors, G-Protein-CoupledReceptors, HistamineCytokinesEpitopesHistamine AntagonistsHrh4 protein, mouseReceptors, G-Protein-CoupledReceptors, HistamineReceptors, Histamine H1Receptors, Histamine H4

Identifiers

PMID24503582
PMCPMC3913588
OpenAlexW2070301595

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.